Cargando…
Type I IFN immunoprofiling in COVID-19 patients
Autores principales: | Trouillet-Assant, Sophie, Viel, Sebastien, Gaymard, Alexandre, Pons, Sylvie, Richard, Jean-Christophe, Perret, Magali, Villard, Marine, Brengel-Pesce, Karen, Lina, Bruno, Mezidi, Mehdi, Bitker, Laurent, Belot, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189845/ https://www.ncbi.nlm.nih.gov/pubmed/32360285 http://dx.doi.org/10.1016/j.jaci.2020.04.029 |
Ejemplares similares
-
Type‐I Interferon assessment in 45 minutes using the FilmArray(®) PCR platform in SARS‐CoV‐2 and other viral infections
por: Mommert, Marine, et al.
Publicado: (2021) -
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021) -
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021) -
Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients
por: Pescarmona, Rémi, et al.
Publicado: (2021) -
Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
por: Goncalves, David, et al.
Publicado: (2021)